...
首页> 外文期刊>Nature biotechnology >Batch effects in the BRLMM genotype calling algorithm influence GWAS results for the Affymetrix 500K array
【24h】

Batch effects in the BRLMM genotype calling algorithm influence GWAS results for the Affymetrix 500K array

机译:BRLMM基因型调用算法中的批次效应影响Affymetrix 500K阵列的GWAS结果

获取原文
获取原文并翻译 | 示例
           

摘要

The Affymetrix GeneChip Human Mapping 500K array is common for genome-wide association studies (GWASs). Recent findings highlight the importance of accurate genotype calling algorithms to reduce the inflation in Type I and Type II error rates. Differential results due to genotype calling errors can introduce severe bias in case-control association study results. Using data from the Wellcome Trust Case Control Consortium, 1991 individuals with coronary artery disease (CAD) and 1500 controls from the UK Blood Services (NBS) were genotyped on the Affymetrix 500K array. Different batch sizes and compositions were used in the Bayesian Robust Linear Model with Mahalanobis distance classifier (BRLMM) genotype calling algorithm to assess the batch effect ondownstream association analysis. Results show that composition (cases and controls genotyped simultaneously or separate) and size (number of individuals processed by BRLMM at a time) can create 2-3% discordance in the results for quality control and statistical analysis and may contribute to the lack of reproducibility between GWASs. The changes in batch size are largely responsible for differential single-nucleotide polymorphism results, yet we observe evidence of an interactive effect of batch size and composition that contributes to discordant results in the list of significantly associated loci.
机译:Affymetrix GeneChip Human Mapping 500K阵列在全基因组关联研究(GWAS)中很常见。最近的发现强调了准确的基因型调用算法对于减少I型和II型错误率膨胀的重要性。由于基因型调用错误而导致的差异结果可能会在病例对照研究结果中引入严重偏差。使用来自Wellcome Trust病例对照协会的数据,在Affymetrix 500K阵列上对1991年患有冠状动脉疾病(CAD)的患者和来自英国血液服务(NBS)的1500名对照进行基因分型。在带有Mahalanobis距离分类器(BRLMM)基因型调用算法的贝叶斯鲁棒线性模型中,使用了不同的批次大小和成分,以评估批次对下游关联分析的影响。结果表明,组成(病例和对照同时进行基因分型或分别进行基因分型)和大小(一次由BRLMM处理的个体数量)会在质量控制和统计分析结果中产生2-3%的不一致,并可能导致缺乏可重复性GWAS之间。批次大小的变化很大程度上是造成差异的单核苷酸多态性结果的原因,但是我们观察到批次大小和组成的交互作用的证据,这导致显着相关的基因座列表中的结果不一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号